Details for New Drug Application (NDA): 202106
✉ Email this page to a colleague
NDA 202106 describes MEROPENEM AND SODIUM CHLORIDE IN DUPLEX CONTAINER, which is a drug marketed by B Braun Medical Inc and is included in one NDA. It is available from one supplier. Additional details are available on the MEROPENEM AND SODIUM CHLORIDE IN DUPLEX CONTAINER profile page.
The generic ingredient in MEROPENEM AND SODIUM CHLORIDE IN DUPLEX CONTAINER is meropenem. There are thirty-two drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the meropenem profile page.
The generic ingredient in MEROPENEM AND SODIUM CHLORIDE IN DUPLEX CONTAINER is meropenem. There are thirty-two drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the meropenem profile page.
Summary for 202106
| Tradename: | MEROPENEM AND SODIUM CHLORIDE IN DUPLEX CONTAINER |
| Applicant: | B Braun Medical Inc |
| Ingredient: | meropenem |
| Patents: | 0 |
Suppliers and Packaging for NDA: 202106
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| MEROPENEM AND SODIUM CHLORIDE IN DUPLEX CONTAINER | meropenem | POWDER;INTRAVENOUS | 202106 | NDA | B. Braun Medical Inc. | 0264-3183 | 0264-3183-11 | 24 CONTAINER in 1 CASE (0264-3183-11) / 50 mL in 1 CONTAINER |
| MEROPENEM AND SODIUM CHLORIDE IN DUPLEX CONTAINER | meropenem | POWDER;INTRAVENOUS | 202106 | NDA | B. Braun Medical Inc. | 0264-3185 | 0264-3185-11 | 24 CONTAINER in 1 CASE (0264-3185-11) / 50 mL in 1 CONTAINER |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | POWDER;INTRAVENOUS | Strength | 500MG/VIAL | ||||
| Approval Date: | Apr 30, 2015 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | RX | Dosage: | POWDER;INTRAVENOUS | Strength | 1GM/VIAL | ||||
| Approval Date: | Apr 30, 2015 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
